Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience
恩科拉非尼联合西妥昔单抗(加或不加比美替尼)治疗BRAF V600E突变转移性结直肠癌患者:来自意大利多中心研究的真实世界数据
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2022.100506
Boccaccino, A; Borelli, B; Intini, R; Antista, M; Bensi, M; Rossini, D; Passardi, A; Tamberi, S; Giampieri, R; Antonuzzo, L; Noto, L; Roviello, G; Zichi, C; Salati, M; Puccini, A; Noto, C; Parisi, A; Rihawi, K; Persano, M; Crespi, V; Libertini, M; Giordano, M; Moretto, R; Lonardi, S; Cremolini, C